0,909  0,002  Caspase 3 stimulant
0,894  0,006  Apoptosis agonist
0,871  0,004  Antipsoriatic
0,792  0,004  Nitric oxide antagonist
0,795  0,016  Antiinflammatory
0,668  0,010  Sensitization
0,663  0,013  Respiratory analeptic
0,653  0,006  Free radical scavenger
0,632  0,028  Transcription factor NF kappa B inhibitor
0,623  0,021  Antileukemic
0,612  0,013  Mutagenic
0,601  0,004  Antiacne
0,623  0,026  CYP3A4 substrate
0,599  0,014  Bone diseases treatment
0,594  0,020  Aldehyde oxidase inhibitor
0,560  0,010  FMO1 substrate
0,560  0,017  Analeptic
0,564  0,025  CYP2C9 substrate
0,572  0,040  Caspase 9 stimulant
0,544  0,021  CYP2C19 substrate
0,525  0,017  Antiosteoporotic
0,520  0,028  Immunosuppressant
0,514  0,022  Carcinogenic
0,512  0,028  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,525  0,041  Alzheimer's disease treatment
0,503  0,022  CTGF expression inhibitor
0,509  0,030  Antipruritic, allergic
0,499  0,021  AR expression inhibitor
0,463  0,017  UGT2B4 substrate
0,464  0,025  Antioxidant
0,437  0,003  Alcohol dehydrogenase substrate
0,463  0,029  Antifungal
0,455  0,026  Cytostatic
0,449  0,031  Cytotoxic
0,448  0,031  Antineoplastic (melanoma)
0,448  0,031  CYP1A2 substrate
0,428  0,020  UGT1A6 substrate
0,437  0,031  Radioprotector
0,439  0,036  Antineoplastic (ovarian cancer)
0,451  0,052  GST A substrate
0,402  0,005  Antineoplastic antibiotic
0,402  0,009  Alpha-N-acetylglucosaminidase inhibitor
0,453  0,060  TNF expression inhibitor
0,457  0,064  Antineoplastic (breast cancer)
0,421  0,031  UGT1A9 substrate
0,408  0,020  Antineoplastic (endocrine cancer)
0,393  0,012  UGT2B7 substrate
0,416  0,042  Teratogen
0,373  0,002  Aldehyde dehydrogenase substrate
0,394  0,026  Antihypoxic
0,379  0,012  Interferon gamma antagonist
0,383  0,019  Anesthetic general
0,364  0,006  Antifungal enhancer
0,369  0,014  Skin whitener
0,392  0,040  Cardioprotectant
0,372  0,026  DNA synthesis inhibitor
0,362  0,019  Skin irritative effect
0,383  0,043  Apoptosis antagonist
0,370  0,032  Chemopreventive
0,353  0,016  Melanin inhibitor
0,380  0,044  Antineoplastic (brain cancer)
0,360  0,025  UDP-glucuronosyltransferase substrate
0,347  0,012  UGT2B15 substrate
0,379  0,045  Embryotoxic
0,378  0,045  NOS3 expression inhibitor
0,400  0,077  Antibacterial
0,373  0,052  Hepatic disorders treatment
0,351  0,033  Antiparasitic
0,326  0,008  UGT2B9 substrate
0,348  0,034  Antineoplastic (liver cancer)
0,342  0,031  Antiulcerative
0,333  0,022  Hepatoprotectant
0,330  0,026  Antihelmintic
0,322  0,033  Antineoplastic (bladder cancer)
0,338  0,055  Antineoplastic (pancreatic cancer)
0,314  0,032  Abortion inducer
0,313  0,032  Wound healing agent
0,294  0,017  Antiviral (Influenza A)
0,283  0,007  UGT2B10 substrate
0,338  0,062  CYP2D6 substrate
0,303  0,029  Antiviral (Influenza)
0,331  0,064  Calcium channel activator
0,337  0,070  Prostate cancer treatment
0,283  0,020  Phospholipase C inhibitor
0,314  0,053  Chemoprotective
0,292  0,032  UGT1A4 substrate
0,310  0,049  Proliferative diseases treatment
0,330  0,070  Immunostimulant
0,281  0,026  Antipruritic, non-allergic
0,265  0,011  Expectorant
0,300  0,048  GST M1-1 substrate
0,276  0,026  Contraceptive
0,299  0,054  Flavin-containing monooxygenase substrate
0,272  0,028  Macular degeneration treatment
0,247  0,005  Actinic keratosis treatment
0,280  0,037  UGT1A1 substrate
0,296  0,058  Antipyretic
0,267  0,030  Neurotrophic factor enhancer
0,251  0,018  Aldehyde dehydrogenase inhibitor
0,244  0,013  Neurotrophic factor
0,231  0,007  HIV-1 integrase (Strand Transfer) inhibitor
0,280  0,060  Antiprotozoal (Leishmania)
0,231  0,014  Antirickettsial
0,277  0,063  Antineoplastic (renal cancer)
0,275  0,061  Cardiovascular analeptic
0,251  0,039  Pneumotoxic
0,228  0,019  Antitussive
0,215  0,010  Phosphofructokinase-1 inhibitor
0,234  0,031  Protein kinase stimulant
0,231  0,031  Carcinogenic, group 3
0,296  0,101  Antineoplastic (lung cancer)
0,204  0,015  Growth stimulant
0,260  0,073  Antineoplastic (non-small cell lung cancer)
0,284  0,100  ICAM1 expression inhibitor
0,226  0,043  Growth factor agonist
0,268  0,085  Antineoplastic (multiple myeloma)
0,207  0,027  Arachidonic acid antagonist
0,185  0,006  Anabolic
0,194  0,016  Adenylate cyclase stimulant
0,223  0,046  Antimutagenic
0,183  0,006  UGT2B11 substrate
0,250  0,074  Antineoplastic (glioma)
0,236  0,061  Peptidyltransferase inhibitor
0,188  0,014  Porphobilinogen synthase inhibitor
0,248  0,074  NOS2 expression inhibitor
0,177  0,005  Hypercalcemia treatment
0,172  0,008  Paget's disease treatment
0,244  0,080  Vascular (periferal) disease treatment
0,258  0,094  FMO3 substrate
0,203  0,041  Aldehyde oxidase substrate
0,200  0,042  Lipid peroxidase inhibitor
0,195  0,037  Genotoxic
0,205  0,049  Eye irritation, high
0,225  0,069  Antiparkinsonian, rigidity relieving
0,169  0,014  Ca2+-transporting ATPase inhibitor
0,155  0,006  Transcription factor AP-1 inhibitor
0,235  0,086  Antihypercholesterolemic
0,185  0,037  SULT1A3 substrate
0,170  0,023  UDP-glucose 4-epimerase inhibitor
0,161  0,016  Xanthine oxidase substrate
0,219  0,075  Antineoplastic (glioblastoma multiforme)
0,219  0,075  RNA-directed DNA polymerase inhibitor
0,169  0,029  Microtubule formation inhibitor
0,154  0,015  Glutamate dehydrogenase inhibitor
0,153  0,014  Keratolytic
0,148  0,012  Ornithine decarboxylase inhibitor
0,169  0,037  Antieczematic
0,159  0,027  Contraceptive female
0,143  0,013  Purinergic P2X2 antagonist
0,223  0,094  Hypoglycemic
0,166  0,042  Toll-Like receptor 2 antagonist
0,129  0,010  Purinergic P2X1 antagonist
0,125  0,007  Antimycoplasmal
0,150  0,032  Mucolytic
0,182  0,065  Succinate dehydrogenase inhibitor
0,179  0,063  UGT1A3 substrate
0,127  0,013  Na+ K+ transporting ATPase inhibitor
0,158  0,044  Antihyperlipoproteinemic
0,139  0,025  Androgen antagonist
0,142  0,032  Sulfotransferase substrate
0,139  0,030  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,133  0,026  Triose-phosphate isomerase inhibitor
0,277  0,172  Alpha-glucosidase inhibitor
0,110  0,005  Glucose-6-phosphate translocase inhibitor
0,162  0,058  Antineoplastic (squamous cell carcinoma)
0,177  0,073  Lipocortins synthesis antagonist
0,129  0,028  Antispirochetal
0,201  0,100  Antineoplastic (cervical cancer)
0,132  0,032  Antiprotozoal (Toxoplasma)
0,132  0,035  Adenylate kinase inhibitor
0,100  0,004  Pregnane X receptor antagonist
0,233  0,137  Antineoplastic (osteosarcoma)
0,121  0,027  Antibiotic
0,160  0,067  Acute respiratory distress syndrome (ARDS) treatment
0,162  0,069  Antiviral (Herpes)
0,140  0,050  Cholesterol synthesis inhibitor
0,133  0,045  TRPA1 agonist
0,155  0,069  Acaricide
0,090  0,004  Parathyroid hormone antagonist
0,107  0,022  GABA aminotransferase inhibitor
0,141  0,056  Antihemorrhagic
0,231  0,149  Sodium/bile acid cotransporter inhibitor
0,158  0,076  Uterine stimulant
0,091  0,012  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,108  0,029  Histidine decarboxylase inhibitor
0,196  0,119  DNA damaging
0,084  0,008  Glucose-6-phosphate isomerase inhibitor
0,096  0,019  Alcohol oxidase inhibitor
0,110  0,035  NADH dehydrogenase inhibitor
0,184  0,109  VCAM1 expression inhibitor
0,089  0,015  SULT2A1 substrate
0,083  0,009  Anesthetic inhalation
0,124  0,052  Carcinogenic, group 2B
0,149  0,078  Aldose reductase substrate
0,124  0,053  SULT1A1 substrate
0,129  0,060  Alkylator
0,138  0,068  Anesthetic
0,122  0,053  Glutathione S-transferase substrate
0,204  0,135  Radiosensitizer
0,121  0,053  Estrogen antagonist
0,108  0,041  ABCA1 expression enhancer
0,071  0,004  Vitamin D receptor antagonist
0,118  0,051  AMP-activated protein kinase stimulant
0,206  0,140  5 Hydroxytryptamine uptake stimulant
0,114  0,048  GST T1-1 substrate
0,091  0,027  Glycine receptor agonist
0,121  0,056  Photosensitizer
0,105  0,040  Antidote, mercury
0,109  0,047  Estrogen receptor beta antagonist
0,104  0,044  Antiviral (Rhinovirus)
0,104  0,044  Thioredoxin inhibitor
0,112  0,054  Beta glucuronidase inhibitor
0,136  0,078  Mannose-6-phosphate isomerase inhibitor
0,091  0,034  Estrogen receptor alpha antagonist
0,080  0,025  Neuraminidase (influenza) inhibitor
0,211  0,155  Cholesterol antagonist
0,121  0,066  Adenylate cyclase inhibitor
0,111  0,056  GABA C receptor agonist
0,082  0,028  Carbamoyl phosphate synthetase inhibitor
0,095  0,042  Granulocyte macrophage colony stimulating factor agonist
0,145  0,091  Carcinogenic, group 1
0,101  0,048  SULT1E1 substrate
0,112  0,060  Ferrochelatase inhibitor
0,077  0,026  Androgen agonist
0,074  0,023  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,070  0,020  Phosphorylase inhibitor
0,077  0,027  Argininosuccinate synthase inhibitor
0,262  0,212  5 Hydroxytryptamine release inhibitor
0,101  0,054  GST P1-1 substrate
0,069  0,022  Postcoital contraceptive
0,075  0,029  Biliverdin reductase inhibitor
0,089  0,044  Glycine receptor antagonist
0,182  0,138  Interleukin agonist
0,110  0,068  Monophenol monooxygenase inhibitor
0,053  0,012  Retinoic acid alpha receptor agonist
0,059  0,018  Cholesterol esterase inhibitor
0,131  0,090  Antiprotozoal (Coccidial)
0,068  0,028  Acyl-CoA dehydrogenase inhibitor
0,179  0,139  Antihypotensive
0,086  0,046  NAD(P)H dehydrogenase (quinone) inhibitor
0,122  0,084  Bone formation stimulant
0,171  0,133  Tumour necrosis factor alpha release inhibitor
0,057  0,020  Adenylate cyclase 1 inhibitor
0,116  0,080  Sphingosine 1-phosphate receptor 4 antagonist
0,114  0,078  Antiviral (Hepatitis B)
0,104  0,069  Excitatory amino acid transporter EAAC1 inhibitor
0,041  0,006  Retinoic acid receptor agonist
0,114  0,080  Antiviral (Influenza B)
0,137  0,103  CF transmembrane conductance regulator agonist
0,055  0,021  Microtubule stabilization
0,155  0,124  CYP2B6 inhibitor
0,080  0,049  Antidote, organophosphates
0,062  0,032  Lipocortins synthesis agonist
0,159  0,129  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,069  0,039  HIV-1 integrase (3'-Processing) inhibitor
0,058  0,029  Alpha-mannosidase inhibitor
0,069  0,041  Glutamate (mGluR6) antagonist
0,179  0,150  Antineoplastic (colorectal cancer)
0,136  0,108  Prostate disorders treatment
0,077  0,049  SULT1A2 substrate
0,041  0,014  Tubulin agonist
0,059  0,032  Protein 50S ribosomal subunit inhibitor
0,098  0,074  UGT2B1 substrate
0,045  0,021  5-Alpha-reductase inhibitor
0,141  0,118  3C-like protease (Human coronavirus) inhibitor
0,037  0,014  Glutamate (mGluR3) agonist
0,092  0,069  Creatine kinase inhibitor
0,031  0,010  CYP24 inhibitor
0,104  0,083  Myasthenia Gravis treatment
0,028  0,008  Retinoic acid gamma receptor agonist
0,031  0,012  Retinoid X gamma receptor antagonist
0,093  0,075  Antiviral (Poxvirus)
0,023  0,005  Telomerase stimulant
0,170  0,152  Nitric-oxide synthase stimulant
0,061  0,043  Neuraminidase inhibitor
0,096  0,079  Choleretic
0,039  0,022  Antibiotic Aminoglycoside-like
0,166  0,149  Antineoplastic (colon cancer)
0,066  0,051  Gaucher disease treatment
0,155  0,140  Antialcoholic
0,024  0,009  Retinoic acid beta receptor agonist
0,080  0,067  Estrogen-related receptor beta agonist
0,168  0,155  5 Hydroxytryptamine release stimulant
0,042  0,030  Guanylate cyclase inhibitor
0,032  0,020  RNA-directed RNA polymerase stimulant
0,101  0,090  Antineoplastic antimetabolite
0,033  0,022  Catechol O-methyltransferase inhibitor
0,048  0,038  Squalene epoxidase inhibitor
0,078  0,068  Antineoplastic alkaloid
0,024  0,013  GRP78 expression inhibitor
0,072  0,063  Narcotic antagonist
0,152  0,143  Antineoplastic (lymphoma)
0,023  0,015  Prostaglandin F2 alpha agonist
0,023  0,016  Retinoid X gamma receptor agonist
0,054  0,047  Botulinum neurotoxin type A inhibitor
0,025  0,018  Vanilloid 2 agonist
0,016  0,010  Purinergic P2Y1 agonist
0,143  0,138  Antihypertriglyceridemic
0,078  0,073  Transcription factor NF kappa B stimulant
0,042  0,037  Mannosidase inhibitor
0,081  0,077  Contraceptive male
0,007  0,003  Transcortin receptor antagonist
0,018  0,015  Antibiotic Anthracycline-like
0,018  0,014  Retinoic acid receptor antagonist
0,020  0,017  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,066  0,064  CYP2A6 inhibitor
0,063  0,061  Anticholelithogenic
0,078  0,076  T cell inhibitor
0,004  0,003  Vitamin D-like
0,129  0,128  Movement disorders treatment
0,017  0,016  Methylmalonyl-CoA mutase inhibitor
0,015  0,014  Vitamin D receptor agonist
0,026  0,026  Purinergic P2Y15 antagonist
0,212  0,212  Antineoplastic (small cell lung cancer)
0,057  0,057  Heme oxygenase stimulant

